1. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Issue 3 (March 2021) Authors: Hoskin, Peter; Popova, Biliana; Schofield, Oliver; Brammer, Caroline; Robinson, Martin; Brunt, A Murray; Madhavan, Krishnaswamy; Illidge, Tim; Gallop-Evans, Eve; Syndikus, Isabel; Clifton-Hadley, Laura; Kirkwood, Amy A Journal: Lancet oncology Issue: Volume 22:Issue 3(2021) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib consolidation post‐ASCT as frontline therapy for multiple myeloma deepens disease response and MRD‐negative rate whilst maintaining QOL and response to re‐treatment at relapse. (20th November 2018) Authors: Cohen, Oliver C.; Counsell, Nicholas; Rabin, Neil; Popat, Rakesh; Owen, Roger G.; Popova, Bilyana; Schofield, Oliver; Clifton‐Hadley, Laura; Lyons‐Lewis, Janet; Rawstron, Andy; Spence, Christopher; de Tute, Ruth M.; Hughes, Derralynn; Moore, Sally; Smith, Paul; Yong, Kwee L. Journal: British journal of haematology Issue: Volume 185:Number 5(2019) Page Start: 948 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗